Initial Performance of a Modified Daily Disposable Silicone Hydrogel Contact Lens
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Alcon Research
- Enrollment
- 81
- Primary Endpoint
- Incidence (Number) of Ocular Discomfort Device-related Adverse Events (AEs)
Study Overview
Brief Summary
The purpose of this study is to evaluate the incidence of ocular discomfort device-related adverse events with DAILIES TOTAL1® with UV Absorber (DT1 UV) contact lenses compared with current DAILIES TOTAL1® (DT1) contact lenses.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Other
- Masking
- Double (Participant, Investigator)
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Must sign an Informed Consent document;
- •Current wearers of commercial DT1 lenses (for at least 3 months), with a minimum wearing time of 5 days per week and 8 hours per day;
- •Spherical contact lens correction within the range of -2.00 to -4.00 Diopter (D) in both eyes;
- •Manifest astigmatism less than or equal to 0.75 D (at screening);
- •Best-corrected visual acuity (BCVA) greater than or equal to 20/25 in each eye (as determined by manifest refraction at screening);
- •Other protocol-specified inclusion criteria may apply.
Exclusion Criteria
- •Eye injury in either eye within 12 weeks prior to study enrollment;
- •Any anterior segment infection, inflammation, disease, or abnormality that contraindicates contact lens wear as determined by the Investigator;
- •Use of systemic or ocular medications for which contact lens wear could be contraindicated, including topical ocular medications and lubrication drops that would require instillation during contact lens wear;
- •History of herpetic keratitis;
- •History of refractive surgery or irregular cornea;
- •Pathologically dry eye that precludes contact lens wear;
- •Concurrent participation (or within the previous 30 days) in a contact lens or lens care product clinical trial;
- •Monocular (only 1 eye with functional vision);
- •Other protocol-specified exclusion criteria may apply.
Arms & Interventions
DT1 UV
Delefilcon A contact lenses with Ultraviolet (UV) Absorber worn bilaterally (in both eyes) for 9 hours
Intervention: Delefilcon A contact lenses with UV Absorber (Device)
DT1
Delefilcon A contact lenses worn bilaterally for 9 hours
Intervention: Delefilcon A contact lenses (Device)
Outcomes
Primary Outcomes
Incidence (Number) of Ocular Discomfort Device-related Adverse Events (AEs)
Time Frame: Day 1 at Hour 9 ± 3 hours
An AE was defined as any untoward medical occurrence in a subject who is administered a study treatment regardless of whether or not the event has a causal relationship with the treatment. Reported in units of eyes.
Secondary Outcomes
No secondary outcomes reported